Last update 08 May 2026

QLS1317

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
QLS-1317
Target-
Action-
Mechanism-
Therapeutic Areas
Neoplasms
Active Indication
MSI-H/dMMR Solid TumorsAdvanced Malignant Solid NeoplasmMicrosatellite instability-high cancer
Inactive Indication-
Originator Organization
Shanghai Qilu Pharmaceutical Research Center Co., Ltd.
Active Organization
Shanghai Qilu Pharmaceutical Research Center Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with QLS1317
NCT07552376
/ Not yet recruitingPhase 1
A Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of QLS1317 in Participants With Advanced Solid Tumors Characterized by Microsatellite Instability-High (MSI-H)/Deficient DNA Mismatch Repair (dMMR) Advanced Solid Tumors
100 Clinical Results associated with QLS1317
Login to view more data
100 Translational Medicine associated with QLS1317
Login to view more data
100 Patents (Medical) associated with QLS1317
Login to view more data
100 Deals associated with QLS1317
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MSI-H/dMMR Solid TumorsPhase 1-
Shanghai Qilu Pharmaceutical Research Center Co., Ltd.
01 May 2026
Advanced Malignant Solid NeoplasmPhase 1
China
Shanghai Qilu Pharmaceutical Research Center Co., Ltd.
15 Apr 2026
Microsatellite instability-high cancerPhase 1
China
Shanghai Qilu Pharmaceutical Research Center Co., Ltd.
15 Apr 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free